BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15266533)

  • 21. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting an oral contraceptive agent for the treatment of acne in women.
    van Vloten WA; Sigurdsson V
    Am J Clin Dermatol; 2004; 5(6):435-41. PubMed ID: 15663340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2010 Mar; (3):CD003552. PubMed ID: 20238323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
    Vartiainen M; de Gezelle H; Broekmeulen CJ
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003552. PubMed ID: 18254023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
    Lucky AW; Koltun W; Thiboutot D; Niknian M; Sampson-Landers C; Korner P; Marr J
    Cutis; 2008 Aug; 82(2):143-50. PubMed ID: 18792547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.
    Zimmerman Y; Eijkemans MJ; Coelingh Bennink HJ; Blankenstein MA; Fauser BC
    Hum Reprod Update; 2014; 20(1):76-105. PubMed ID: 24082040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
    Visser J; Snel M; Van Vliet HA
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Truitt ST; Fraser AB; Grimes DA; Gallo MF; Schulz KF
    Cochrane Database Syst Rev; 2003; (2):CD003988. PubMed ID: 12804497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006133. PubMed ID: 17443615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Tang JH; Lopez LM; Mody S; Grimes DA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009805. PubMed ID: 23152281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris.
    Koo EB; Petersen TD; Kimball AB
    J Am Acad Dermatol; 2014 Sep; 71(3):450-9. PubMed ID: 24880665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet H; Grimes D; Helmerhorst F; Schulz K
    Cochrane Database Syst Rev; 2001; (4):CD003283. PubMed ID: 11687185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination contraceptives: effects on weight.
    Gallo MF; Lopez LM; Grimes DA; Schulz KF; Helmerhorst FM
    Cochrane Database Syst Rev; 2011 Sep; (9):CD003987. PubMed ID: 21901687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.